GU Cancers Symposium 2014 - Effect of prior abiraterone or enzalutamide on sipuleucel-T manufacture in PROCEED patients - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Nicholas J. Vogelzang, Jeffrey L. Vacirca, Philip W. Kantoff, Mark Creamer Scholz, Shaker R. Dakhil, Luke T. Nordquist, Celestia S. Higano, A. Oliver Sartor, Matthew R. Cooperberg, Andrew Sandler, Candice McCoy, James Boyd Whitmore, Robert Claude Tyler, and Andrew J. Armstrong at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 Vogelzang Sip-T thumb

 

Comprehensive Cancer Centers of Nevada, Las Vegas, NV; National Translational Research Group, East Setauket, NY; Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA; Prostate Oncology Specialists, Marina del Rey, CA; Cancer Center of Kansas, Wichita, KS; Urology Cancer Center & GU Research Network, Omaha, NE; University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Tulane University School of Medicine, New Orleans, LA; University of California, San Francisco, San Francisco, CA; Dendreon Corporation, Seattle, WA; Duke University, Durham, NC

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland